Key Facts Surrounding This News Item
- GTHX had returned 0.00% year-to-date leading up to today’s news, versus a +7.97% return from the benchmark S&P 500 during the same period.
More Info About G1 Therapeutics, Inc. (GTHX)
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel therapeutics for the treatment of cancer in the United States. The company was founded in 2008 and is based in Research Triangle Park, North Carolina. View our full GTHX ticker page with ratings, news, and more.